dc.contributor.author | Lunnon, K | |
dc.contributor.author | Hannon, E | |
dc.contributor.author | Smith, RG | |
dc.contributor.author | Dempster, E | |
dc.contributor.author | Wong, C | |
dc.contributor.author | Burrage, J | |
dc.contributor.author | Troakes, C | |
dc.contributor.author | Al-Sarraj, S | |
dc.contributor.author | Kepa, A | |
dc.contributor.author | Schalkwyk, L | |
dc.contributor.author | Mill, J | |
dc.date.accessioned | 2016-03-01T10:08:25Z | |
dc.date.issued | 2016-02-16 | |
dc.description.abstract | BACKGROUND: The most widely utilized approaches for quantifying DNA methylation involve the treatment of genomic DNA with sodium bisulfite; however, this method cannot distinguish between 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). Previous studies have shown that 5hmC is enriched in the brain, although little is known about its genomic distribution and how it differs between anatomical regions and individuals. In this study, we combine oxidative bisulfite (oxBS) treatment with the Illumina Infinium 450K BeadArray to quantify genome-wide patterns of 5hmC in two distinct anatomical regions of the brain from multiple individuals. RESULTS: We identify 37,145 and 65,563 sites passing our threshold for detectable 5hmC in the prefrontal cortex and cerebellum respectively, with 23,445 loci common across both brain regions. Distinct patterns of 5hmC are identified in each brain region, with notable differences in the genomic location of the most hydroxymethylated loci between these brain regions. Tissue-specific patterns of 5hmC are subsequently confirmed in an independent set of prefrontal cortex and cerebellum samples. CONCLUSIONS: This study represents the first systematic analysis of 5hmC in the human brain, identifying tissue-specific hydroxymethylated positions and genomic regions characterized by inter-individual variation in DNA hydroxymethylation. This study demonstrates the utility of combining oxBS-treatment with the Illumina 450k methylation array to systematically quantify 5hmC across the genome and the potential utility of this approach for epigenomic studies of brain disorders. | en_GB |
dc.description.sponsorship | This work was funded by NIH grant AG036039 to JM, UK Medical Research Council grant MR/K013807/1 to JM, and Alzheimer’s Association New Investigator Research Grant NIRG-14-320878 to KL. | en_GB |
dc.identifier.citation | Vol. 17, article 27 | en_GB |
dc.identifier.doi | 10.1186/s13059-016-0871-x | |
dc.identifier.uri | http://hdl.handle.net/10871/20293 | |
dc.language.iso | en | en_GB |
dc.publisher | BioMed Central | en_GB |
dc.relation.url | http://www.ncbi.nlm.nih.gov/pubmed/26883014 | en_GB |
dc.relation.url | http://hdl.handle.net/10871/34190 | |
dc.rights | © 2016 Lunnon et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. | en_GB |
dc.title | Variation in 5-hydroxymethylcytosine across human cortex and cerebellum. | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2016-03-01T10:08:25Z | |
exeter.place-of-publication | England | |
dc.description | This is the final version of the article. It first appeared from BioMed Central via http://dx.doi.org/10.1186/s13059-016-0871-x | en_GB |
dc.description | The erratum to this article is in ORE: http://hdl.handle.net/10871/34190 | |
dc.identifier.eissn | 1474-760X | |
dc.identifier.journal | Genome Biology | en_GB |